Ribai Yan

Development of a Novel Class of Glucose Transporter Inhibitors

Dasheng Wang, Po‐Chen Chu, Chia‐Ning Yang et al. · Journal of Medicinal Chemistry · 2012 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

RETRACTED: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells

I‐Lu Lai, Chih-Chien Chou, Po‐Ting Lai et al. · Carcinogenesis · 2014 · 37 citations · Full text

Medicine, Oncology, Pharmacology +15

ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo

Rajeswaran Mani, Chi‐Ling Chiang, Frank Frissora et al. · Experimental Hematology · 2015 · 23 citations · Full text

Medicine, Oncology, Pharmacology +14

Exploitation of the Ability of γ-Tocopherol to Facilitate Membrane Co-localization of Akt and PHLPP1 to Develop PHLPP1-Targeted Akt Inhibitors

Ribai Yan, Hsiao-Ching Chuang, Naval Kapuriya et al. · Journal of Medicinal Chemistry · 2015 · 12 citations · Full text

Life Sciences, Molecular Biology, Oncology +13